NASDAQ:BMEA

Biomea Fusion Stock Predictions

etoro logo Buy BMEA
*Your capital is at risk
$1.30
-0.0700 (-5.11%)
At Close: Jun 03, 2026
Currently predicting for Thu, 4 Jun 2026

BMEA Prediction Chart

BMEA Predictions History

Latest community submissions for BMEA.
Predictor Target Session Target Price Result Direction Accuracy Score
Jan 22, 2026 $1.46 +3.29% $1.43 V 98.16% 1
Jan 22, 2026 $1.44 +2.05% $1.43 V 99.37% 4
Jan 22, 2026 Bullish $1.43 V 1
Oct 8, 2025 $1.94 +5.15% $1.68 X 84.52% 0
Oct 7, 2025 $2.25 -15.73% $1.85 V 78.05% 1
Jun 4, 2025 $2.40 -3.72% $2.86 X 83.82% 0
Jun 4, 2025 $2.43 -2.33% $2.86 X 85.04% 0
Jun 4, 2025 Bullish $2.86 V 1
Mar 28, 2025 $2.59 +3.90% $2.30 X 87.52% 0
Mar 28, 2025 $2.55 +2.44% $2.30 X 89.10% 0
Click to get the best stock tips daily for free!
Forecast Desk

Request A 3-Month Forecast

Ask an approved predictor to map the next 66 trading days for BMEA with a full price path, not just a one-day call.
  • Price path
  • Approved predictor
  • 3-month horizon
ABOUT BIOMEA FUSION, INC.
Biomea Fusion
Biomea Fusion, Inc., a biopharmaceutical company, focuses on the discovery and development of irreversible small molecules to treat patients with genetically defined cancers and metabolic diseases. Its lead product candidate is BMF-219, an orally bioavailable, potent, and selective irreversible inhibitor of menin, a transcriptional regulator in oncogenic signaling in multiple cancers. The company was incorporated in 2017 and is headquartered in R...
GOLDEN STAR
Ticker Change Signal Date
LITE
$905.00
3.65% Jun 01
RUN
$12.83
15.74% May 06
GLBE
$31.61
0.569% May 05
SAP
$172.39
4.80% May 05
ADBE
$243.57
5.20% Apr 29

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE